Global survey of the diagnostic evaluation and management of cryptogenic ischemic stroke

International Journal of Stroke

Volumn 10, Issue 7, 2015, Pages 1031-1036

  Giruparajah, Mohana ^a   Bosch, Jackie ^a   Vanassche, Thomas ^a   Mattina, Katie ^a   Connolly, Stuart J ^a   Pater, Calin ^b   Hart, Robert G ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b BAYER PHARMA AG   (Germany)

Author keywords

Antiplatelet; Cryptogenic stroke; Diagnosis; Embolic stroke; Stroke; Stroke prevention

Indexed keywords

ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT;

AFRICA SOUTH OF THE SAHARA; ANTICOAGULANT THERAPY; ARTICLE; ASIA; BRAIN ISCHEMIA; CARIBBEAN; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; EUROPE; GEOGRAPHY; HEALTH SURVEY; HEART RHYTHM; HUMAN; INCOME; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE EAST; NORTH AFRICA; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PRIORITY JOURNAL; SECONDARY PREVENTION; SOUTH AND CENTRAL AMERICA; SOUTH ASIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPLICATION; COMPUTED TOMOGRAPHY SCANNER; ELECTROCARDIOGRAPHY; FEMALE; HEALTH; MALE; ONLINE SYSTEM; QUESTIONNAIRE; STROKE;

BRAIN ISCHEMIA; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; GLOBAL HEALTH; HEALTH SURVEYS; HUMANS; MALE; ONLINE SYSTEMS; STROKE; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 84942296753     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12509     Document Type: Article

References (13)

1. Hart RG, Diener H-C, Coutts SB etal. on behalf of the Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014; 13:429-438.
2. Bang OY, Ovbiagele B, Kim JS. Evaluation of cryptogenic stroke with advanced diagnostic techniques. Stroke 2014; 45:1186-1194.
3. Kishore A, Vail A, Majid A etal. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack. A systematic review and meta-analysis. Stroke 2014; 45:520-526.
4. Culebras A, Messe SR, Chaturvedi S, Kase CS, Gronseth G. Evidence-based guideline: Prevention of stroke in nonvalvular atrial fibrillation. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014; 82:716-724.
5. Gladstone DJ, Spring M, Dorian P etal. for the EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014; 370:2467-2477.
6. Sanna T, Diener H-C, Passman RS etal. for the CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370:2478-2486.
7. Kamel H. Heart-rhythm monitoring for evaluation of cryptogenic stroke. N Engl J Med 2014; 2532-2533.
8. Amarenco P, Davis S, Jones EF etal. for the Aortic Arch Related Cerebral Hazard Trial Investigators. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke 2014; 45:1248-1257.
9. European Stroke Organization (ESO) Executive Committee and ESO Writing Committee. Guidelines for the management of ischemic stroke and transient ischemic attack 2008. Cerebrovas Dis 2008; 25:457-505.
10. Kernan WN, Ovbiagele B, Black HR etal. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45:2160-2236.
11. Lansberg MG, O'Donnell MJ, Khatri P etal. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl.):e601S-636. doi: 10.1378/chest.11-2302.
12. Diener H-C. Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicyclic acid in patients with embolic stroke of undetermined source (RE-SPECT ESUS). European Stroke Conference, OAID 3 Ongoing Trials 23, Nice, France, May 6-8, 2014. NCT02239120. Available at http://clinicaltrials.gov (accessed 1 April 2015).
13. NAVIGATE ESUS. Publically-available information (cite the press release on 29 August 2014 and perhaps later the abstract to be published in STROKE for the ISC meeting in February 2015) NCT02313909. Available at http://clinicaltrials.gov (accessed 1 April 2015).